| The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo S Jostes, D Nettersheim, M Fellermeyer, S Schneider, F Hafezi, ... Journal of cellular and molecular medicine 21 (7), 1300-1314, 2017 | 90 | 2017 |
| SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate D Nettersheim, A Heimsoeth, S Jostes, S Schneider, M Fellermeyer, ... Oncotarget 7 (30), 47095, 2016 | 51 | 2016 |
| Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate SV Jostes, M Fellermeyer, L Arévalo, GE Merges, G Kristiansen, ... International journal of cancer 146 (6), 1592-1605, 2020 | 36 | 2020 |
| LARP1 isoform expression in human cancer cell lines H Schwenzer, M Abdel Mouti, P Neubert, J Morris, J Stockton, S Bonham, ... RNA biology 18 (2), 237-247, 2021 | 12 | 2021 |
| The current state and future of T-cell exhaustion research E Jenkins, T Whitehead, M Fellermeyer, SJ Davis, S Sharma Oxford Open Immunology 4 (1), iqad006, 2023 | 10 | 2023 |
| The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes RAS Barreiro, GDA Guardia, FM Meliso, X Lei, WQ Li, A Savio, ... RNA biology 20 (1), 311-322, 2023 | 3 | 2023 |
| Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases AH Lippert, C Paluch, M Gaglioni, MT Vuong, J McColl, E Jenkins, ... Immunity 57 (2), 256-270. e10, 2024 | 2 | 2024 |
| Combination CD200R/PD-1 blockade in a humanised mouse model M Fellermeyer, C Anzilotti, C Paluch, RJ Cornall, SJ Davis, U Gileadi Immunotherapy Advances 3 (1), ltad006, 2023 | 2 | 2023 |
Sumana SharmaThe MRC Weatherall Institute of Molecular Medicine (MRC WIMM)Verified email at rdm.ox.ac.uk
